Clinical News

Clinical Status

<div class="articleContainer"><div class="articleWrapper"><div class="articleContent"><h1 class="text title">CerAxon citicoline: IPIC began its fourth Phase III trial</h1><div class="byline">WIR Staff</div><div class="date"></div></div></div></div>

VTJGc2RHVmtYMSsxTTl5Tno1VkNwRC83d0VFaGwvRjdBVlpaRkoxdGFPVHNwNDJsRlc5cHVzYzRSdGFJc1MyYkhnblZzRmFkZlM2OXZQNUVBbmJIdmJEZEg1am9VRlRHYy9JVEgrSUxGcjNHNjVWdXBBUGR0bUtoY3pzcFBRTFdXTHRoNHZrSFlMOE05alY3MFBvSUZrK3NKZ3o4NDlzRjhKY1U5c04yRmhrU2VsMVFZd3p3WnNtYkw4ekFiL2ZXSnRkeWFTSmh3cVdtU0g2WEJTcnhDbklvRi9uVk8vR0x3Qk1IRDIyYmhTKzBscGdOZ0s3Ui8xRzdHTzBrWmJPdS9lR1o5OWNzYUw3MnByWldDWXNUbVRQaUNxRC9QaGZBa3g2dTNuanhEc3cyUmM1VjVUelN4UmgwZkFpM2xYa2VXQ1VWYkZwWUs0OW1BZVNnQlBIUzltZXNidmdCWEc2RWVXV2tXdXp3Y3YyVjFKeTdlaDFTQThrS0xKZllxWEwwNCtMZTJCU0N4TERDdDVnb2tmNi9uUGRjUjYwY0oveVpNaXE4dHlqYytkTlgwMzVob1c5MXJqUy9zeFBUT1NLOWR6dVRMOTR3SW4xZUNnRzhsZ0cvc0NkVTZyalNKSGtpaDVKQk5GRk1hY01aRk1laSswQnk1enRMVU9qaE4zVi9CajhDUXdTalR3YkU3dmVmcEo0Y3FYNXZTUlZrNHd1eGxwS2pGb0JhQUU0QmNUQUE1L3V4WmxwTVVTWEc2cXc0OXFxM3dpRmtuWURFNmpqSGZ0aEkxcFN3c1BLRjdaK1ZvdGNsdFdtK2xxb3VvVitrWmh1NzA4NW9aeGFGZm9lVDJWNXJwdTdoTTBUQ3hwWXkySmhPUnNKdXp6emEwRG1CMUl5T2dDdWc2bHhwZHpjYWJ5blg5WGp4bmllcnNJVGZnOG1Lc210YjA1citrOEJVWlM2WnZ6QkIyYnh0ZmNpZjl4WkpabzlZLzZnWGdpQ2tZMmhhaGVRaVN3eFR6UWcybXVXMXcxclh4MHBqUkh6Q2VpTWdsVjBCbTh0SDNsbFlMS0RWbCtyVkRDREpwYUh3aWRVU3ZzSFhhRDVNa2o4SXEvZmF5YkQ0ay81UGdvb3BiWk5IVjZoQjFRcGp2YWxtV1VOVVFobnVoQUw0M0Vud3Z6alF5N3BrNG5FMnBNMk5sd1k5cGd1VjZmQ0FFbHFLSGNKSHBJRmovVTh4cEc4QkIySjFRZEJqVXJrQldIMkNVNFdDYkRkTk4yWm56VHdIWDNlK1JKTFRKRVNUTDBIaU1tMG9pVEFBTXRURm1RSUkrdG82dmptRndLalBiZENnY29WeEtHZ1JMUXV2amZtNVk0OTVaS1EyZloybGpYMVFHVkU0OGZ5dU16NVd3S0pMVlZ2RkZmaFpqY1paTUwrNUZnelZVMnJMTmV3MDg2UkNlU3JoUUpyNGkyVUhYbnpPUWI4aWNaUktpY3loSVdjK1ZWWWZQa1pGVXNtTngzNXpoc0NIMWVjRzY5NW9NK3Q4b2xLcllGM0h5RDdBaHhEczY3bU13UHl3NDhBeVZzbkFINHliVDBwZzFBckR0b3I5Uy96aDNSOGw5UXZ2N2dVQ200aWlrTXFQYWJmSi9hNzBtY2YrTzFCM3ZHMDEzUW0xUytKRExDNXM4ZzB1d3BXQVMzYUxEMTVYQlVzYmZBNG1XQjlRSmdad0dLRloreDdQWkQ4TzBRPT0=

(Ferrer licenses citicoline rights, B4) ......

Neurology

CerAxon citicoline: IPIC began its fourth Phase III trial

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Discovery & Translation Analysis

Discovery & Translation

Hot Topics

BioCentury Podcasts 

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data Coverage

BCIQ Data

All Events

At the East-West Summit, you will meet key players looking to globalize innovation from across Asia.

East-West Biopharma Summit

Bio€quity Europe

Grand Rounds — U.S.

Grand Rounds — Europe

The BioCentury-BayHelix China Healthcare Summit

China Healthcare Summit

Podcast: The BioCentury Show

Podcast: BioCentury This Week

Webinars

Events

My Workspace

Management

Analysts & Research Team

Scientific Advisory Board

About BioCentury

Contact Us

Forgot Password

Request a Subscription

Sponsorship & Branding Inquiry

Media Kit

Request BioCentury's BCIQ Brochure

Customer Resource Center

Career Opportunities

Request a Trial

Contact

Home